AI Airlock Sandbox Phase 2 Programme Report
The MHRA’s AI Airlock second phase ran between April 2025 and May 2026. This report does not constitute formal MHRA guidance.
Documents
Details
The AI Airlock programme report contains a comprehensive overview of the methodology for establishing the regulatory sandbox, an overview of the seven case studies and the lessons learned from the independent programme evaluation. ThisThe report also summarises the key technical and regulatory insights and recommendations for changes to the regulatory and support framework for AI as a medical device.
Also included on this page is the detailed innovator case study reports. These have been drafted by the innovators and do not constitute MHRA guidance or policy.
Updates to this page
-
Added AI Airlock Sandbox Phase 2 Innovator case study reports
-
First published.
Update history
2026-07-17 11:11
Added AI Airlock Sandbox Phase 2 Innovator case study reports
2026-06-09 11:37
First published.